AbbVie Inc (ABBV) stock news · P/E 81, rev $61.16B
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
This ABBV news page leads with what AbbVie Inc filed — not a scraped headline mill.
No cached 8-K sentence for ABBV yet. We will not pad this page with generic market recap.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 8.6% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.7.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ABBV stock page; for the tape open the quote page.
ABBV stock news FAQ
What are ABBV's latest revenue and net income?
Latest cached AbbVie Inc (ABBV) revenue for Dec 31, 2025 was $61.16B. Net income was $4.23B. Statements: https://lician.com/financials/abbv
How did ABBV revenue change from the prior cached period?
Cached AbbVie Inc (ABBV) revenue was up 8.6% from $56.33B (Dec 31, 2024) to $61.16B (Dec 31, 2025). Statements: https://lician.com/financials/abbv
What is ABBV's P/E ratio?
AbbVie Inc (ABBV) trailing P/E is 80.7 on the latest cached fundamentals snapshot.
What is ABBV's market cap?
AbbVie Inc (ABBV) market cap is $334.34B on the latest cached fundamentals snapshot.
What kind of company is ABBV?
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US.
Where is ABBV stock news listed?
Cached stock news for AbbVie Inc (ABBV) is listed at https://lician.com/news/abbv. Filings: https://lician.com/sec/abbv
Not investment advice.